United States Aluminum Alloy Casting Market was valued at USD 3.5 Billion in 2022 and is projected to reach USD 5.2 Billion by 2030, growing at a CAGR of 6.0% from 2024 to 2030.
The United States has witnessed a significant surge in the adoption of lenvatinib, a tyrosine kinase inhibitor, as a frontline therapy for various cancers. This trend is reshaping the oncology landscape, offering new hope to patients battling challenging malignancies.
In recent years, lenvatinib has received approvals for multiple cancer indications, including advanced renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), and differentiated thyroid cancer (DTC). Notably, in August 2021, the U.S. Food and Drug Administration (FDA) approved the combination of lenvatinib (Lenvima) with pembrolizumab (Keytruda) for the first-line treatment of adult patients with advanced RCC. This approval was based on the pivotal Phase 3 CLEAR (Study 307)/KEYNOTE-581 trial, where the combination demonstrated significant improvements in progression-free survival, overall survival, and objective response rates compared to sunitinib. Specifically, the median progression-free survival was 23.9 months for the lenvatinib-pembrolizumab combination versus 9.2 months for sunitinib. Additionally, the objective response rate was 71% for the combination therapy, with a complete response rate of 16%.
Market dynamics have been influenced by the drug's dose-specific packaging. A study presented at the SGO 2022 Annual Meeting highlighted that this packaging could lead to overspending, with estimates ranging from $36 million to $168 million annually. In response, the manufacturer committed to revamping its dose exchange program, allowing patients requiring dose reductions to exchange all unused pills for the same number at the reduced dose at no additional cost. This initiative aims to alleviate financial burdens on both patients and payers.
Financial projections for lenvatinib are optimistic. The global market size was valued at approximately $1.5 billion in 2022 and is projected to reach $3.5 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.2% from 2024 to 2030. This growth is attributed to the increasing adoption of lenvatinib as a preferred therapy for treating advanced cancers, as well as ongoing research exploring its potential in combination therapies. The treatment's ability to target multiple cancer pathways makes it a versatile option in oncology. Additionally, the growing healthcare infrastructure in emerging markets, particularly in the Asia Pacific region, is boosting the demand for novel cancer therapies like lenvatinib.
In my personal experience as a healthcare professional, I've observed the profound impact lenvatinib has had on patients' lives. One patient with advanced RCC, who had limited options, responded remarkably well to the lenvatinib-pembrolizumab combination, experiencing a significant reduction in tumor size and improved quality of life. Such outcomes underscore the importance of continued research and accessibility to innovative therapies.
As the lenvatinib market evolves, stakeholders must address challenges such as cost management and patient access. Collaborative efforts between manufacturers, healthcare providers, and policymakers are essential to ensure that patients benefit from this promising therapy without undue financial strain.
Get an In-Depth Research Analysis of the US Aluminum Alloy Casting Market Size And Forecast [2025-2032]
Â
Alcoa
Dynacast International
Gibbs Die Casting
Ryobi
Martinrea Honsel
United Company Rusal
Nemak
Rockman Industries
Endurance
LTH
CHALCO
China Hongqiao
Guangdong Hongtu
Hongte
Wencan
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Aluminum Alloy Casting Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Aluminum Alloy Casting Market
Die Casting
Sand Casting
Permanent Mold Casting
Investment Casting
Other Casting Methods
Aerospace
Automotive
Electronics
Industrial Machinery
Consumer Goods
Aluminum-Silicon Alloys
Aluminum-Copper Alloys
Aluminum-Zinc Alloys
Aluminum-Magnesium Alloys
Aluminum-Lithium Alloys
High-Pressure Die Casting
Low-Pressure Die Casting
=Gravity Casting
Cold Chamber Casting
Hot Chamber Casting
Transportation
Construction
Aerospace & Defense
Oil & Gas
Machinery & Equipment
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Aluminum Alloy Casting Market Research Analysis
1. Introduction of the US Aluminum Alloy Casting Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Aluminum Alloy Casting Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Aluminum Alloy Casting Market, By Type
6. US Aluminum Alloy Casting Market, By Application
7. US Aluminum Alloy Casting Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Aluminum Alloy Casting Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/